CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (59,801)	$ (32,609)
Adjustments to reconcile net loss to cash used in operating activities:
Impairment of intangible assets	1,488	78
Amortization and depreciation	2,858	1,248
Amortization of right-of-use asset	733	288
Amortization of inventory step-up	978
Unrealized loss on investment	5	6,994
GVB fire write-offs	4,549
Realized loss on short-term investment securities	366
Change in allowance for doubtful accounts	770
Gain on the sale of machinery and equipment	(368)
Realized loss (gain) on Panacea investment	2,789	(2,548)
Accretion of non-cash interest expense (income), net	197	143
Equity-based employee compensation expense	5,489	3,983
Deferred income taxes	(434)
Inventory write-off	237	317
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	(2,881)	1,574
Inventory	(8,789)	(1,164)
Prepaid expenses and other assets	(920)	(547)
Accounts payable	416	11
Accrued expenses	(582)	533
Accrued payroll	748	47
Accrued excise taxes and fees	153	(421)
Other liabilities	285	(766)
Net cash used in operating activities	(51,714)	(22,839)
Cash flows from investing activities:
Acquisition of patents, trademarks, and licenses	(772)	(326)
Acquisition of property, plant and equipment	(3,657)	(745)
Proceeds from the sale of machinery and equipment	409
Acquisition, net of cash acquired and debt assumed	(1,297)
Investment in Change Agronomy Ltd.	(682)
Sales and maturities of short-term investment securities	101,990	63,749
Purchase of short-term investment securities	(73,413)	(90,407)
Net cash provided by (used in) investing activities	22,578	(27,729)
Cash flows from financing activities:
Payment on note payable	(3,822)	(2,604)
Proceeds from note payable issuance	2,162	2,653
Other financing activities	(29)
Net proceeds from option exercise	174	1,307
Net proceeds from warrant exercise		11,782
Proceeds from issuance of common stock	35,000	40,000
Payment of common stock issuance costs	(2,516)	(1,794)
Taxes paid related to net share settlement of RSUs	(149)	(469)
Net cash provided by financing activities	30,820	50,875
Net increase in cash and cash equivalents	1,684	307
Cash and cash equivalents - beginning of period	1,336	1,029
Cash and cash equivalents - end of period	3,020	1,336
Net cash paid for:
Cash paid during the period for interest	34	37
Cash paid during the period for income taxes	14
Non-cash transactions:
Capital expenditures incurred but not yet paid	$ 94	1,074
Right-of-use assets and corresponding operating lease obligations		1,816
Panacea investment conversion		$ 12,485
Stock issued in connection with acquisition	51,653